Joslin ClinicalFOCUS™ Satellite Broadcast

Blunting Macrovascular Risk: New Perspectives on Metabolic Interventions

This activity is no longer available as a satellite broadcast or via telephone. You can register to participate in the archived Web cast of the broadcast by clicking on the link at the bottom of the page.

If you have already participated in this activity and are seeking CME credit, go to the Online Posttest.  Select the posttest for the format that you used to participate. You will need the 6-digit access code found in the activity study guide.

STATEMENT OF NEED
The significant morbidity and mortality of macrovascular disease has been thought to result from the growing epidemic of the key clinical macrovascular risk factors: diabetes, obesity, dyslipidemia, and hypertension. At-risk individuals are typically manifesting a number of early signs or symptoms which should trigger the initiation of interventions aimed at arresting - or slowing - the vasculopathic process.

The focus of this educational activity is on methods to impact risk of vascular disease and clinical strategies for earlier and more effective intervention to prevent macrovascular disease in the clinical arena.

LEARNING OBJECTIVES
Participants will be provided with clinically relevant, evidence-based information. At the completion of this activity, the participant should be able to:

• Identify metabolic risk factors and describe their role in increasing macrovascular risk
• Intervene in at-risk individuals with aggressive preventive strategies targeting multiple risk factors, including diabetes, hypertension, dyslipidemia, and coagulopathies
• Design treatments specifically targeting vascular function as part of, or in augmentation of, risk factor-specific intervention
• Integrate effective and practical risk-reduction strategies in the clinical setting

TARGET AUDIENCE
This accredited activity has been designed for primary care physicians and other healthcare professionals who treat patients with diabetes and its related conditions.

FACULTY
Moderator
Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director, Professional Education
Joslin Diabetes Center
Boston, MA

Presenters
Robert E. Heinig, MD
Clinical Professor of Medicine
University of Rochester Medical School
Chief of Endocrinology
Rochester General Hospital
Rochester, NY

Jeffrey L. Probstfield, MD, FACP, FACC, FAHA
Director, Clinical Trials Service Unit
Professor of Medicine (Cardiology)
University of Washington School of Medicine
Adjunct Professor of Epidemiology
University of Washington School of Public Health and Community Medicine
Affiliate Member, Fred Hutchinson Cancer Research Center
Seattle, WA

ACCREDITATION AND DESIGNATION OF CREDIT
The Joslin Diabetes Center, Boston is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Joslin Diabetes Center designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit.™ Physicians should only claim credit commensurate with the extent of their participation in the activity. 

This CME activity was planned and produced in accordance with ACCME Essentials.

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEUs) in states that recognize ACPE.

To receive enduring credit, you must pass the posttest with a score of at least 70% and complete the evaluation form.  Statements of CE Credit will be issued by the University of Florida College of Pharmacy upon proof of successful completion of the activity. UPN #012-999-06-120-H01

i3 DLN is an approved provider of continuing nursing education by the Utah Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. The participant will be awarded 1.2 contact hours of credit for attendance and completion of supplemental materials.

Participants not eligible for the continuing education credits outlined above will receive a certificate of participation.

FACULTY DISCLOSURE
It is the policy of Joslin Diabetes Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty participating in CME activities sponsored by Joslin Diabetes Center are expected to present evidence-based data, identify and reference off-label product use, and disclose all relevant financial relationships with those supporting the activity or any others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This activity is supported by an educational grant from Wyeth Pharmaceuticals and King Pharmaceuticals, Inc.

REGISTER NOW for this Joslin ClinicalFOCUS activity as an archived Webcast